Promacta 50 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4E0F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,294
Award facts
- Contract value 100% obligated
- $42,293.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $42,293.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Promacta 50 mg tablets (30-count units) under a non-competitive, non-set-aside contract. The delivery order, issued on December 23, 2025, with an ultimate completion date of January 15, 2026, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December 2026 that supplies a comprehensive range of medications and medical supplies to support military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its established relationship with the Defense Logistics Agency. The company's federal contract portfolio demonstrates extensive experience delivering both brand-name and generic pharmaceuticals across multiple therapeutic areas to military and veteran healthcare systems. Promacta is an immunosuppressant medication used in treating certain blood disorders, and this delivery order reflects the company's ongoing role in supporting the Defense Health Agency and other government healthcare entities through the DLA's Medical Supply Chain network.
Quick answers
Who was awarded contract SPE2DR26F4E0F?
SPE2DR26F4E0F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26F4E0F worth?
The government has obligated $42,294 on SPE2DR26F4E0F.
Is contract SPE2DR26F4E0F an order under another contract?
Yes. SPE2DR26F4E0F is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4E0F competed?
The extent of competition for SPE2DR26F4E0F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award